FDA approves once-daily Zerit
BY Advocate.com Editors
January 03 2003 12:00 AM ET
The Food and Drug Administration on Tuesday approved a new, extended-release form of the HIV nucleoside reverse transcriptase inhibitor Zerit (d4T), which will be marketed as Zerit XR by drugmaker Bristol-Myers Squibb. The new formulation can be taken just once a day. Data from clinical trials of the medication show that it is as effective as the standard twice-daily dosing of d4T and that reducing the pill burden may help people with HIV better stick to their anti-HIV drug regimens.
- Brad Pitt and Angelina Jolie Support Their Kid Wearing Suits
- #TBT: They Died in the Closet
- Did Nickelodeon Just Confirm Legend of Korra Same-Sex Romance?
- This Year's Coolest Straight People in Entertainment
- Freddy Krave Is His Own Best Model
- WATCH: Laverne Cox Caught in Middle of Screaming Match on The View